{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:26:07Z","timestamp":1789147567211,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2020-84"],"award-info":[{"award-number":["2020-84"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2020YFN0152"],"award-info":[{"award-number":["2020YFN0152"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973189"],"award-info":[{"award-number":["81973189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174193"],"award-info":[{"award-number":["82174193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U19A2010"],"award-info":[{"award-number":["U19A2010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.phymed.2021.153802","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T11:42:27Z","timestamp":1634643747000},"page":"153802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Myricetin exhibit selective anti-lymphoma activity by targeting BTK and is effective via oral administration in vivo"],"prefix":"10.1016","volume":"93","author":[{"given":"Xiaominting","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153802_bib0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-6-59","article-title":"Ibrutinib and novel BTK inhibitors in clinical development","volume":"6","author":"Akinleye","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2021.153802_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14305","article-title":"Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways","volume":"1467","author":"Al-Bari","year":"2020","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"10091","key":"10.1016\/j.phymed.2021.153802_bib0003","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phymed.2021.153802_bib0004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12272-015-0698-0","article-title":"Molecular modeling studies on series of BTK inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach","volume":"39","author":"Balasubramanian","year":"2016","journal-title":"Arch. Pharm. Res."},{"issue":"17","key":"10.1016\/j.phymed.2021.153802_bib0005","doi-asserted-by":"crossref","first-page":"7643","DOI":"10.1021\/acs.jmedchem.9b00794","article-title":"Discovery of evobrutinib: an oral, potent, and highly selective, covalent Bruton's tyrosine kinase (BTK) inhibitor for the treatment of immunological diseases","volume":"62","author":"Caldwell","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phymed.2021.153802_bib0006","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2213-2600(20)30505-1","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome","volume":"9","author":"Camporota","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.phymed.2021.153802_bib0007","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1158\/1535-7163.MCT-17-0597","article-title":"Path toward precision oncology: review of targeted therapy studies and tools to aid in defining \"Actionability\" of a molecular lesion and patient management support","volume":"16","author":"Chae","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"14","key":"10.1016\/j.phymed.2021.153802_bib0008","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1158\/1078-0432.CCR-20-1427","article-title":"BTK inhibitors in cancer patients with COVID-19: \"The winner will be the one who controls that Chaos\" (Napoleon Bonaparte)","volume":"26","author":"Chong","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phymed.2021.153802_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12032-019-1267-z","article-title":"Interaction between phytotherapy and oral anticancer agents: prospective study and literature review","volume":"36","author":"Clairet","year":"2019","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2021.153802_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","article-title":"Diffuse large B-cell lymphoma: R-CHOP failure-what to do?","author":"Coiffier","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"issue":"4","key":"10.1016\/j.phymed.2021.153802_bib0011","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.19082\/6672","article-title":"Medical uses of carthamus tinctorius L. (Safflower): a comprehensive review from traditional medicine to modern medicine","volume":"10","author":"Delshad","year":"2018","journal-title":"Electron Physician"},{"key":"10.1016\/j.phymed.2021.153802_bib0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ctrv.2018.01.002","article-title":"Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma","volume":"65","author":"Dunleavy","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.phymed.2021.153802_bib0013","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1021\/acs.jmedchem.0c00597","article-title":"A fast and clean BTK inhibitor","volume":"63","author":"Gabizon","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phymed.2021.153802_bib0014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.phymed.2021.153802_bib0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"272","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.phymed.2021.153802_bib0016","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/modpathol.3800176","article-title":"Divergent cyclin B1 expression and Rb\/p16\/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors","volume":"17","author":"Igarashi","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.phymed.2021.153802_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1760137","article-title":"Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease","author":"Joshi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"34","key":"10.1016\/j.phymed.2021.153802_bib0018","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.20.00157","article-title":"Stem cell transplantation and vinblastine monotherapy for relapsed pediatric anaplastic large cell lymphoma: results of the International, Prospective ALCL-relapse trial","volume":"38","author":"Kn\u00f6rr","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phymed.2021.153802_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231543","article-title":"Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein","volume":"15","author":"Lalitha","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2021.153802_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2018.03.062","article-title":"The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: a mini-review","volume":"151","author":"Liang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.phymed.2021.153802_bib0021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/foods9030373","article-title":"Effects of hot-water extract from vine tea (Ampelopsis grossedentata) on acrylamide formation, quality and consumer acceptability of bread","volume":"9","author":"Ma","year":"2020","journal-title":"Foods"},{"issue":"6","key":"10.1016\/j.phymed.2021.153802_bib0022","doi-asserted-by":"crossref","first-page":"e95184","DOI":"10.1371\/journal.pone.0095184","article-title":"Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2","volume":"9","author":"Mahadevan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2021.153802_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","author":"Mancinelli","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"20","key":"10.1016\/j.phymed.2021.153802_bib0024","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1021\/jf061538c","article-title":"Metabolite profiling of grape: flavonols and anthocyanins","volume":"54","author":"Mattivi","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phymed.2021.153802_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ctrv.2017.06.001","article-title":"Bruton's tyrosine kinase (BTK) as a promising target in solid tumors","volume":"58","author":"Molina-Cerrillo","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.phymed.2021.153802_bib0026","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1039\/c2fo10274a","article-title":"Target molecules of food phytochemicals: food science bound for the next dimension","volume":"3","author":"Murakami","year":"2012","journal-title":"Food Funct."},{"issue":"11","key":"10.1016\/j.phymed.2021.153802_bib0027","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/molecules25112707","article-title":"Potential of flavonoid-inspired phytomedicines against COVID-19","volume":"25","author":"Ngwa","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.phymed.2021.153802_bib0028","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nri955","article-title":"Regulation of B-cell fate by antigen-receptor signals","volume":"2","author":"Niiro","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2021.153802_bib0029","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/bjh.15619","article-title":"Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based haematological malignancy research network","volume":"185","author":"Painter","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.phymed.2021.153802_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.critrevonc.2019.02.001","article-title":"Management of adverse effects\/toxicity of ibrutinib","volume":"136","author":"Paydas","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.phymed.2021.153802_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2019.00095","article-title":"Toll-like receptor signaling drives BTK-mediated autoimmune disease","volume":"10","author":"Rip","year":"2019","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.phymed.2021.153802_bib0032","doi-asserted-by":"crossref","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"issue":"Pt A","key":"10.1016\/j.phymed.2021.153802_bib0033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.phrs.2016.09.011","article-title":"Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms","volume":"113","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phymed.2021.153802_bib0034","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/nu8020090","article-title":"Myricetin: a dietary molecule with diverse biological activities","volume":"8","author":"Semwal","year":"2016","journal-title":"Nutrients"},{"issue":"9844","key":"10.1016\/j.phymed.2021.153802_bib0035","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.phymed.2021.153802_bib0036","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2021.153802_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111017","article-title":"Myricetin: a review of the most recent research","volume":"134","author":"Song","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phymed.2021.153802_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11130-013-0349-x","article-title":"Biological activities of extracts from Chinese bayberry (Myrica rubra Sieb. et Zucc.): a review","volume":"68","author":"Sun","year":"2013","journal-title":"Plant Foods Hum. Nutr."},{"key":"10.1016\/j.phymed.2021.153802_bib0039","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3389\/fimmu.2019.01862","article-title":"Tyrosine kinases in autoimmune and inflammatory skin diseases","volume":"10","author":"Szilveszter","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phymed.2021.153802_bib0040","first-page":"443","article-title":"2016 US lymphoid malignancy statistics by world health organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.phymed.2021.153802_bib0041","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.phymed.2021.153802_bib0042","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phymed.2021.153802_bib0043","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2021.153802_bib0044","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.phymed.2021.153802_bib0046","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1200\/JCO.2016.70.2282","article-title":"BTKC481S - mediated resistance to ibrutinib in chronic lymphocytic leukemia","volume":"35","author":"Woyach","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2021.153802_bib0047","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-016-0313-y","article-title":"Second-generation inhibitors of Bruton tyrosine kinase","volume":"9","author":"Wu","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.phymed.2021.153802_bib0048","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1039\/D0FO02370A","article-title":"Wild pink bayberry fruit: the effect of in vitro gastrointestinal digestion on phytochemical profiles, and antioxidant and antiproliferative activities","volume":"12","author":"Xia","year":"2021","journal-title":"Food Funct."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321003457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321003457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:14:31Z","timestamp":1778559271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321003457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"alternative-id":["S0944711321003457"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153802","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myricetin exhibit selective anti-lymphoma activity by targeting BTK and is effective via oral administration in vivo","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153802"}}